Medicare Enrolled
Dr. Jing-Sheng Zheng, MD
Cardiovascular Disease · Galloway, NJ
Practice pattern: Cardiac & Cardiac
— Practice combining cardiac and cardiac services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zheng from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zheng?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zheng
Dr. Jing-Sheng Zheng is a cardiovascular disease specialist in Galloway, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zheng performed 2,261 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Zheng received a total of $29,732 from 47 pharmaceutical and/or device companies across 634 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zheng is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 2,261 Medicare services
$29,732 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,261
Medicare services
Bottom 38% in NJ for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
621 | $94 | $280 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
359 | $110 | $312 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
184 | $41 | $123 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
135 | $98 | $218 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
129 | $105 | $288 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
125 | $11 | $32 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
112 | $20 | $54 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
87 | $81 | $231 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
74 | $276 | $773 |
| Transesophageal echocardiogram during heart surgery An ultrasound of the heart performed using a probe inserted into the esophagus while surgery on the heart or major blood vessels is taking place, including a written report. |
72 | $178 | $486 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
50 | $110 | $156 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
37 | $11 | $31 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
33 | $162 | $448 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
31 | $66 | $152 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
30 | $10 | $34 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $125 | $360 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
29 | $19 | $53 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $72 | $198 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
24 | $145 | $422 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
24 | $36 | $64 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
19 | $50 | $160 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
16 | $17 | $47 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
16 | $142 | $395 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
19.1% high complexity
28.1% medium
52.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$29,732
Total received (2018-2024)
Avg $4,247/year across 7 years
Top 8% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
634
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,383
2023
$4,978
2022
$2,759
2021
$1,601
2020
$806
2019
$13,609
2018
$2,597
Payments by company (2024)
Abbott Laboratories
$1,365
E.R. Squibb & Sons, L.L.C.
$401
PFIZER INC.
$315
AstraZeneca Pharmaceuticals LP
$229
Janssen Pharmaceuticals, Inc
$139
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$136
Boston Scientific Corporation
$125
SCPHARMACEUTICALS INC.
$115
ABIOMED
$85
Medtronic, Inc.
$82
Novartis Pharmaceuticals Corporation
$67
Philips North America LLC
$59
Bayer Healthcare Pharmaceuticals Inc.
$55
Kiniksa Pharmaceuticals International, plc
$50
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
Esperion Therapeutics, Inc.
$31
SANOFI-AVENTIS U.S. LLC
$21
Regeneron Healthcare Solutions, Inc.
$17
Lexicon Pharmaceuticals, Inc.
$17
HEARTFLOW, INC.
$17
Merck Sharp & Dohme LLC
$16
Top 3 companies account for 61.5% of 2024 payments
All-time payments by company (2018-2024) ›
Siemens Medical Solutions USA, Inc.
$12,956
Abbott Laboratories
$2,599
Boston Scientific Corporation
$1,948
AstraZeneca Pharmaceuticals LP
$1,318
Janssen Pharmaceuticals, Inc
$1,232
E.R. Squibb & Sons, L.L.C.
$1,036
BOSTON SCIENTIFIC CORPORATION
$1,018
PFIZER INC.
$930
Novartis Pharmaceuticals Corporation
$926
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$810
Medtronic Vascular, Inc.
$658
SANOFI-AVENTIS U.S. LLC
$582
Philips Electronics North America Corporation
$433
Esperion Therapeutics, Inc.
$402
AltaThera Pharmaceuticals LLC
$381
Merck Sharp & Dohme LLC
$374
Medtronic, Inc.
$333
Amgen Inc.
$243
ABIOMED
$176
Boehringer Ingelheim Pharmaceuticals, Inc.
$140
Sunovion Pharmaceuticals Inc.
$130
CSL Behring
$125
Inari Medical, Inc.
$118
SCPHARMACEUTICALS INC.
$115
Amarin Pharma Inc.
$85
Regeneron Healthcare Solutions, Inc.
$69
Merck Sharp & Dohme Corporation
$65
Philips North America LLC
$59
Bayer Healthcare Pharmaceuticals Inc.
$55
Kiniksa Pharmaceuticals International, plc
$50
Biosense Webster, Inc.
$45
Kowa Pharmaceuticals America, Inc.
$43
GE HealthCare
$42
Gilead Sciences, Inc.
$35
Edwards Lifesciences Corporation
$21
Aegerion Pharmaceuticals, Inc.
$19
Lexicon Pharmaceuticals, Inc.
$17
HEARTFLOW, INC.
$17
Daiichi Sankyo Inc.
$17
Fisher & Paykel Healthcare Inc
$16
W. L. Gore & Associates, Inc.
$16
iRhythm Technologies, Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$14
ATRICURE, INC.
$14
PORTOLA PHARMACEUTICALS, INC.
$13
Althera Pharmaceuticals LLC
$12
Preventice Services, LLC
$11
Top 3 companies account for 58.9% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (5050) Extended Holter · (9520) IGT Devices Und · ACUSON SC2000 Diagnostic Ultrasound System · AMPLATZER AMULET · ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) · Arcalyst · BEVYXXA · BG Mini Plus · BRILINTA · CAMZYOS · CARTO 3 · CHANTIX · COREVALVE EVOLUT R · CoreValve Evolut · Corlanor · DAKLINZA · ELIQUIS · ENTRESTO · EVKEEZA · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · GORE CARDIOFORM Septal Occluder · Haegarda · INJECTAFER · Impella · JARDIANCE · JUXTAPID · Kerendia · LEQVIO · LOKELMA · LONHALA MAGNAIR · LifeVest · Livalo · MITRACLIP · MULTAQ · NEXLETOL · NEXLIZET · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RESONATE · Ranexa · Repatha · Roszet · S · SC2000 · Sotalol Hydrochloride · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO XT Patch
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
38
County median income
$76,819
Nearest hospital to ZIP centroid (approximate)
ATLANTICARE REGIONAL MEDICAL CENTER - CITY CAMPUS
7.2 mi
7.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zheng is a cardiac & cardiac specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zheng experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Zheng performed 621 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Zheng receive payments from pharmaceutical companies?
Yes. Dr. Zheng received a total of $29,732 from 47 companies across 634 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zheng's costs compare to other cardiologists in Galloway?
Dr. Zheng's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zheng) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Galloway
Browse cardiologists in Galloway ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Siemens Medical Solutions USA, Inc. Payments to Doctors
See all physicians who received payments from Siemens Medical Solutions USA, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology